More than two years after the launch of the PECAN fast-track process, valuable lessons have emerged. Hélène Viatgé and Stéphane Tholander, Co-CEOs of Agora Health, will share an update on PECAN’s application to Digital Therapeutics (DTx) and Remote Patient Monitoring (RPM) solutions. The session will include an overview of approved submissions, common pitfalls, and learnings from recent rejections.
More than two years after the launch of the PECAN fast-track process, valuable lessons have emerged. Hélène Viatgé and Stéphane Tholander, Co-CEOs of Agora Health, will share an update on PECAN’s application to Digital Therapeutics (DTx) and Remote Patient Monitoring (RPM) solutions. The session will include an overview of approved submissions, common pitfalls, and learnings from recent rejections.
More than two years after the launch of the PECAN fast-track process, valuable lessons have emerged. Hélène Viatgé and Stéphane Tholander, Co-CEOs of Agora Health, will share an update on PECAN’s application to Digital Therapeutics (DTx) and Remote Patient Monitoring (RPM) solutions. The session will include an overview of approved submissions, common pitfalls, and learnings from recent rejections.
